From: In vitro models of cancer stem cells and clinical applications
Type of cancer | Species | Cancer cell line/tumour | Reprogramming factors | Characterization of the pluripotency state | Teratoma ? | Chimera ? | Tumour description | Ref. | |
---|---|---|---|---|---|---|---|---|---|
Gastro intestinal cancer | Pancreatic cancer | Human | Primary solid tumour from patients | Oct4, Sox2, Klf4, c-Myc | Nanog, Oct4, Rex1, Ssea-4, sphere formation and differentiation into three germ layers | Yes | - | PanIN precursors to PDAC, evolution to the invasive stage | [69] |
Liver cancer | Human | Cancer cell line PLC/PRF/5 | mir-302 | Nanog Oct4 Sox2, Rex1, alkaline phosphatase activity, sphere formation and differentiation into three germ layers | - | - | - | [99] | |
Human | Oct4, Sox2, Klf4, c-Myc | Nanog, Oct4, Klf4, Rex1, Ssea-4, Tra-1-60, sphere formation and differentiation into three germ layers | - | - | - | [56] | |||
Oct4, Sox2, Klf4, c-Myc | c-Myc, Sox2, Oct4, Klf4, Nanog, Rex1, Tra-1-60, Tra-1-81, Tra-2-49, Ssea-4, multi-differentiation potential into three germ layers | - | - | - | [60] | ||||
Cholangio carcinoma | Human | Cancer cell line HuCC-T1 | - | Enhanced tumorigenicity | |||||
Colorectal cancer | Human | Cancer cell line DLD-1 | - | - | - | ||||
Oct4, Sox2, Klf4, c-Myc | Nanog, Oct3/4, Sox2, Klf4, c-Myc, Rex1, Ssea-4, Tra-1-60, Tra-1-81, Tra-2-49, sphere formation and differentiation into three germ layers | - | - | - | [57] | ||||
Human | Cancer cell lines SW480 and SW620 | Oct4, Sox2, Klf4, c-Myc | Sox2, Oct4, Lin28, sphere formation | - | - | Enhanced tumorigenicity | [59] | ||
Human | Cancer cell line SW480 | Oct4, Sox2, Klf4 | Sphere formation | - | - | Enhanced tumorigenicity | [98] | ||
Leukaemia | Human | Cancer cell line KBM7 | Oct4, Sox2, Klf4, c-Myc | Oct4, Sox2, Rex1, FGF4, TDGF1, Nanog, GDF3, Lin28, Zic3, CD9, Tra-1-81, alkaline phosphatase activity, sphere formation | Yes | - | - | [66] | |
Human | CD34+ cells from patients with CML | Oct4, Sox2, Klf4, c-Myc | Oct4, Sox2, Klf4, Nanog, Lin28, Rex1, Ssea-4, Tra-1-60 | Yes | - | - | [67] | ||
Human | Bone marrow mononuclear cells from patient with CML | Oct4, Sox2, Klf4, c-Myc, Nanog, Lin28, | Oct4, Sox2, Nanog, Lin28, GDF3, Rex1, GDF3, Ssea-3, Ssea-4, TrA-1-60, Tra-1-81, alkaline phosphatase activity | Yes | - | - | [68] | ||
Lung cancer | Human | Cancer cell lines H358 and H460 | Oct4, Sox2, Klf4, c-Myc | Nanog, Sox2, FGF4, Oct4, Tra-1-60, alkaline phosphatase activity, telomerase activity, sphere formation and differentiation into three germ layers | - | - | - | [54] | |
Cancer cell line A549 | Oct4, Sox2, Nanog, Lin28, HIF | Alkaline phosphatase activity (partial reprogramming) | - | - | Highly aggressive malignant solid tumors, high mitotic index, local invansiveness | [55] | |||
Oct4, Nanog | Oct4, Nanog, sphere formation | - | - | Enhanced tumorigenicity and metastasis | [32] | ||||
Murine | Lewis lung mouse carcinoma cell line LLC | Conditioned medium for carcinoma cells (role of microenvironment) | Oct3, Oct4, Nanog, Rex1, Ras, Esg1, Cripto | Yes | - | Spheroid and tumor formation in mice, high mitotic index, angiogenesis in vivo | [83] | ||
Sarco mas | Osteosarcoma | Human | Cancer cell lines SAOS2, HOS, MG63 | Oct4, Nanog, Sox2, Lin28, Klf4 and c-Myc | Oct4, Nanog, Sox2, Lin28, Klf4, c-Myc, Tra-1-81, Ssea-4, Rex, alkaline phosphatase activity | - | - | - | [61] |
Liposarcoma | Human | Cancer cell line SW872 | |||||||
Ewing’s sarcoma | Human | Cancer cell line SKNEP | |||||||
Human | Cancer cell line CHLA-10 | Oct4, Sox2, Klf4, Nanog | Tra1-160, Ssea-3, Ssea-4, alkaline phosphatase activity | Yes | - | Various levels of undifferentiated cells, embryoid body and tumor formation in mice | [110] | ||
Breast Cancer | Human | Cancer cell line MCF-7 | Oct4, Sox2, Klf4, c-Myc | Sox2, Ssea-1, Ssea-4, Tra-1–60, Tra-1–81, alkaline phosphatase activity, sphere formation | - | Enhanced tumorigenicity, highly aggressive tumors | [63] | ||
Sox2 | Ssea-4 | - | - | Enhanced tumorigenicity | [64] | ||||
Murine | Mammary carcinoma cell line MCE12 | - | - | - | - | - | [83] | ||
Prostate cancer | Human | Prostate cancer-associated stromal cells from primary tumours | Oct4, Nanog, Sox2, Lin28 | Oct4, Nanog, Lin28, Sox2, alkaline phosphatase activity | - | - | - | [65] | |
Human | Cancer cell line PC3 | mir-302 | Oct4, Nanog, Sox2, Ssea-3, Ssea-4, sphere formation and differentiation into neuronal cells | Yes | - | - | [53] | ||
Melanoma | Murine | Cancer cell line Colo | mir-302 | Sphere formation and differentiation into neuronal cells | - | - | [53] | ||
Cancer cell line R545 | Oct4, Klf4, c-Myc | - | Yes | Yes | - | [52] | |||
Melanoma cell line B16 | - | - | - | - | - | [83] |